Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer

The efficacy and toxicity of oxaliplatin-based versus carboplatin/cisplatin-based doublets in patients with previously untreated nonsmall cell lung cancer (NSCLC) have been compared. We searched published randomized controlled trials of oxaliplatin-based or carboplatin/cisplatin-based medications fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Xiao, Jing, Yang, Yifan, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504603/
https://www.ncbi.nlm.nih.gov/pubmed/26166081
http://dx.doi.org/10.1097/MD.0000000000001072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504603/
https://www.ncbi.nlm.nih.gov/pubmed/26166081
http://dx.doi.org/10.1097/MD.0000000000001072

Ejemplares similares